GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $132,000 | +1000.0% | 207,300 | +685.2% | 0.01% | – |
| Q4 2021 | $12,000 | +140.0% | 26,400 | +161.4% | 0.00% | – |
| Q3 2021 | $5,000 | -58.3% | 10,100 | -18.5% | 0.00% | – |
| Q2 2021 | $12,000 | -20.0% | 12,400 | +13.8% | 0.00% | -100.0% |
| Q1 2021 | $15,000 | -65.1% | 10,900 | -86.9% | 0.00% | -50.0% |
| Q3 2020 | $43,000 | -35.8% | 83,000 | +675.7% | 0.00% | -50.0% |
| Q4 2019 | $67,000 | -41.2% | 10,700 | -86.9% | 0.00% | -55.6% |
| Q3 2019 | $114,000 | -58.7% | 81,400 | -23.0% | 0.01% | -47.1% |
| Q4 2018 | $276,000 | +51.6% | 105,700 | +147.0% | 0.02% | +54.5% |
| Q3 2018 | $182,000 | -78.0% | 42,800 | -71.0% | 0.01% | -73.2% |
| Q2 2018 | $828,000 | -38.1% | 147,800 | +433.6% | 0.04% | -38.8% |
| Q1 2018 | $1,338,000 | +35.4% | 27,698 | +10.3% | 0.07% | +63.4% |
| Q4 2017 | $988,000 | +814.8% | 25,105 | -51.7% | 0.04% | +583.3% |
| Q2 2017 | $108,000 | -79.2% | 52,000 | -63.9% | 0.01% | -81.2% |
| Q1 2017 | $518,000 | – | 144,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |